Håkan Axelson

5.4k total citations
90 papers, 4.1k citations indexed

About

Håkan Axelson is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Håkan Axelson has authored 90 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 30 papers in Cancer Research and 22 papers in Neurology. Recurrent topics in Håkan Axelson's work include Cancer, Hypoxia, and Metabolism (22 papers), Neuroblastoma Research and Treatments (22 papers) and Renal and related cancers (17 papers). Håkan Axelson is often cited by papers focused on Cancer, Hypoxia, and Metabolism (22 papers), Neuroblastoma Research and Treatments (22 papers) and Renal and related cancers (17 papers). Håkan Axelson collaborates with scholars based in Sweden, United Kingdom and United States. Håkan Axelson's co-authors include Sven Påhlman, Jonas Sjölund, David Lindgren, Annika Jögi, Göran Landberg, Erik Fredlund, Christina Manetopoulos, Terence H. Rabbitts, Martin Johansson and Marie‐Thérése Stockhausen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Håkan Axelson

88 papers receiving 4.1k citations

Peers

Countries citing papers authored by Håkan Axelson

Since Specialization

Citations

This map shows the geographic impact of Håkan Axelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkan Axelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkan Axelson more than expected).

Fields of papers citing papers by Håkan Axelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Håkan Axelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkan Axelson. The network helps show where Håkan Axelson may publish in the future.

Co-authorship network of co-authors of Håkan Axelson

This figure shows the co-authorship network connecting the top 25 collaborators of Håkan Axelson. A scholar is included among the top collaborators of Håkan Axelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Håkan Axelson. Håkan Axelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back again 2023 ·The Journal of Pathology ·Mattias Höglund, Carina Bernardo, Gottfrid Sjödahl, Pontus Eriksson, Håkan Axelson, Fredrik Liedberg	15
2	Dialysis as a Novel Adjuvant Treatment for Malignant Cancers 2022 ·Cancers ·(unknown), Anders Nilsson, Jan Sternby, Carl M. Öberg, Kristian Pietras, Håkan Axelson, Ana Carneiro, Sara Kinhult, Anders Christensson, (unknown), (unknown), (unknown), (unknown), (unknown), Viktoria Roos	0
3	The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2 2021 ·Cancer Research ·Tracy J. Berg, Carolina Marques, Vasiliki Pantazopoulou, (unknown), Kristoffer von Stedingk, David Lindgren, Pauline Jeannot, (unknown), Tobias Bergström, Fredrik J. Swartling, Valeria Governa, Johan Bengzon, Mattias Belting, Håkan Axelson, Massimo Squatrito, Alexander Pietras	32
4	Tracing Renal Cell Carcinomas back to the Nephron 2018 ·Trends in cancer ·David Lindgren, Jonas Sjölund, Håkan Axelson	17
5	Overexpression of Functional SLC6A3 in Clear Cell Renal Cell Carcinoma 2016 ·Clinical Cancer Research ·Jennifer Hansson, David Lindgren, Helén Nilsson, (unknown), Martin Johansson, Lena Gustavsson, Håkan Axelson	22
6	snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis 2013 ·Translational Oncology ·Kristoffer von Stedingk, Jan Köster, Marta Piqueras, Rosa Noguera, Samuel Navarro, Sven Påhlman, Rogier Versteeg, Ingrid Øra, David Gisselsson, David Lindgren, Håkan Axelson	22
7	Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney 2013 ·Human Pathology ·Jennifer Hansson, Kjell Hultenby, (unknown), Fredrik Pontén, (unknown), David Lindgren, Håkan Axelson, (unknown)	40
8	Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition 2011 ·Human Pathology ·(unknown), Christina Möller, Elise Nilsson, Peter Elfving, Håkan Axelson, Martin Johansson	38
9	The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma 2010 ·Molecular Cell ·Pieter Mestdagh, (unknown), Francis Impens, Erik Fredlund, Gert Van Peer, Pasqualino De Antonellis, Kristoffer von Stedingk, Bart Ghesquière, Stefanie Schulte, Michael Dews, Andrei Thomas‐Tikhonenko, Johannes H. Schulte, Massimo Zollo, Alexander Schramm, Kris Gevaert, Håkan Axelson, Frank Speleman, Jo Vandesompele	252
10	HIF-1α induces MXI1 by alternate promoter usage in human neuroblastoma cells 2009 ·Experimental Cell Research ·Tobias Löfstedt, Erik Fredlund, Rosa Noguera, Samuel Navarro, Linda Holmquist Mengelbier, Siv Beckman, Sven Påhlman, Håkan Axelson	23
11	Eyeing tumorigenesis: Notch signaling and epigenetic silencing of Rb in Drosophila 2006 ·BioEssays ·Håkan Axelson	6
12	Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells 2005 ·British Journal of Cancer ·M.-T. Stockhausen, Jonas Sjölund, Christina Manetopoulos, Håkan Axelson	113
13	Hypoxia-induced dedifferentiation of tumor cells – A mechanism behind heterogeneity and aggressiveness of solid tumors 2005 ·Seminars in Cell and Developmental Biology ·Håkan Axelson, Erik Fredlund, (unknown), Göran Landberg, Sven Påhlman	237
14	High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells 2005 ·International Journal of Cancer ·(unknown), Christina Manetopoulos, Håkan Axelson, Göran Landberg	47
15	Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression 2004 ·BMC Cancer ·(unknown), Christina Manetopoulos, Håkan Axelson, Mikael Sigvardsson	13
16	Induction of ID2 Expression by Hypoxia-inducible Factor-1 2004 ·Journal of Biological Chemistry ·Tobias Löfstedt, Annika Jögi, Mikael Sigvardsson, Katarina Gradin, Lorenz Poellinger, Sven Påhlman, Håkan Axelson	114
17	LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1. 1997 ·PubMed ·(unknown), Gerald Grütz, Håkan Axelson, A. Förster, Terence H. Rabbitts	25
18	The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas 1995 ·European Journal of Cancer ·Håkan Axelson, (unknown), (unknown), (unknown), George Klein	13
19	Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line 1994 ·European Journal of Cancer ·Stefan Imreh, (unknown), Chinmay Kumar Panda, Magda Babonits, Håkan Axelson, (unknown), Anna Szeles, F. Wiener, George Klein	2
20	Mouse Plasmacytoma Associated (MPC) T(15;16) Translocation Occurs Repeatedly in New MPC Induction System 1990 ·Current topics in microbiology and immunology ·F. Wiener, (unknown), Hiroyuki Sugiyama, Magda Babonits, Håkan Axelson, (unknown), George Klein	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact